Uncommon Therapeutics
PrivateLast Round
Seed
Feb 1, 2025
Total Funding Raised
$500,000
Company Overview
Uncommon Therapeutics is a biotechnology company that develops gene-based and multi-modal therapeutics for rare neurodevelopmental monogenic diseases, with an initial focus on Rett Syndrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Uncommon Therapeutics Comparables
Compare Uncommon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Unravel Biosciences | 76% | |
| Neurogene | 74% | |
| Taysha Gene Therapies | 70% | |
Uncommon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 1, 2025 |
Uncommon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Seed |
| Ethos Fund | Seed |
| Singularity Capital | Seed |
| Y Combinator | Seed |
| Roar Ventures | Seed |
| Angel Operator Partners | Seed |
Uncommon Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Uncommon Therapeutics's valuation, stock price, and market status.